TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis

Long Zhang1, Fangfang Zhou, Amaya García de Vinuesa

  • 1Department of Molecular Cell Biology, Cancer Genomics Centre Netherlands and Centre for Biomedical Genetics, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands; Life Sciences Institute, Zhejiang University, Hangzhou, Zhejiang 310058, China.

Molecular Cell
|August 27, 2013
PubMed

Insights

Tumor necrosis factor receptor-associated factor 4 (TRAF4) promotes cancer by enhancing transforming growth factor beta (TGF-β) signaling. TRAF4 drives TGF-β-induced cell migration and metastasis, indicating its role in breast cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor beta (TGF-β) signaling is a critical pathway implicated in advanced cancers.
  • Targeting TGF-β signaling presents a therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To identify key mediators of pro-oncogenic TGF-β signaling.
  • To investigate the role of tumor necrosis factor receptor-associated factor 4 (TRAF4) in TGF-β-induced oncogenic processes.

Main Methods:

  • Investigated TRAF4's interaction with the TGF-β receptor complex.
  • Assessed the impact of TRAF4 on E3 ligase SMURF2 and deubiquitinase USP15 recruitment.
  • Analyzed TGF-β-activated kinase 1 (TAK1) activation and TRAF4 polyubiquitylation.
  • Correlated TRAF4 expression with patient prognosis and signaling markers.

Main Results:

  • TRAF4 antagonizes SMURF2 and recruits USP15 to the TGF-β type I receptor (TβRI), stabilizing it.
  • TRAF4 interaction with TGF-β receptor triggers Lys 63-linked polyubiquitylation and TAK1 activation.
  • TRAF4 is essential for TGF-β-induced migration, epithelial-to-mesenchymal transition, and metastasis.
  • Elevated TRAF4 expression correlates with increased pSMAD2, pTAK1, and poor breast cancer prognosis.

Conclusions:

  • TRAF4 is a crucial regulator of TGF-β signaling in cancer.
  • TRAF4 enhances TGF-β-mediated oncogenic signaling, contributing to breast cancer pathogenesis and metastasis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...